Ignite Creation Date:
2025-12-24 @ 2:00 PM
Ignite Modification Date:
2026-01-15 @ 3:00 PM
Study NCT ID:
NCT02904395
Status:
COMPLETED
Last Update Posted:
2016-09-19
First Post:
2016-09-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Feasability and Interest of Screening for Infantile Pompe's Diseases at Birth
Sponsor:
Centre Hospitalier de Cayenne
Organization:
Study Overview
Official Title:
Feasability and Interest of Screening for Infantile Pompe's Diseases at Birth
Status:
COMPLETED
Status Verified Date:
2016-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
DEPIPOMP1
Brief Summary:
Given the 100 fold increase of the incidence of Pompe's disease in Western French Guiana, the objective of the present study is to implement systematic screening in newborns in French Guiana in order to start treatment before the muscular and cardiac symptoms appear.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: